Etz Christian D, Homann Tobias M, Silovitz Daniel, Spielvogel David, Bodian Carol A, Luehr Maximilian, DiLuozzo Gabriele, Plestis Konstadinos A, Griepp Randall B
Department of Cardiothoracic Surgery, Mount Sinai School of Medicine, New York, New York 10029, USA.
Ann Thorac Surg. 2007 Oct;84(4):1186-93; discussion 1193-4. doi: 10.1016/j.athoracsur.2007.03.057.
The recognition that patients with a bicuspid aortic valve (BAV) are at risk for aorta-related death (rupture or dissection) has favored composite aortic root replacement in BAV patients who undergo aortic valve replacement for valve dysfunction as well as in asymptomatic BAV patients with significant aortic root dilatation. We report the results of Bentall operations in 206 BAV patients during an 18-year interval.
Two hundred six BAV patients (mean, 53 +/- 14 years, 84% male) underwent composite aortic root replacement between September 1987 and May 2005. One hundred nine patients (53%) presented with aortic regurgitation, 24 patients (12%) presented with aortic stenosis, and 55 patients (26%) presented with combined aortic stenosis and aortic regurgitation. Median preoperative aortic diameter was 5.5 cm (range, 3 to 9 cm). Twenty-two patients (11%) underwent urgent or emergent procedures; 11 had acute type A dissection (5%). Sixty-one percent had a mechanical valve Bentall prosthesis; in 39%, a biologic valve was implanted. Thirty-two percent had concomitant procedures.
Overall hospital mortality was 2.9% (n = 6), and stroke rate was 1.9% (n = 4). Risk factors for adverse outcome (death or stroke), which occurred in 4.8% (n = 10), were presence of clot or atheroma (p = 0.02) and age older than 65 years (p = 0.05). During a mean follow-up of 5.9 years (1,200 patient-years; range, 5 to 18 patient-years), no patient required ascending aortic reoperation. Long-term survival was 93% after 5 years and 89% after 10 years. Discharged patients enjoyed survival equivalent to a normal age- and sex-matched population and superior to survival reported for a series of patients with aortic valve replacement alone.
In patients with BAV, the Bentall procedure has an operative mortality no worse than that for aortic valve replacement, with superior long-term survival and a lower rate of aortic reoperation.
认识到二叶式主动脉瓣(BAV)患者存在主动脉相关死亡(破裂或夹层)风险后,对于因瓣膜功能障碍接受主动脉瓣置换的BAV患者以及有明显主动脉根部扩张的无症状BAV患者,倾向于进行主动脉根部复合置换术。我们报告了18年间206例BAV患者行Bentall手术的结果。
1987年9月至2005年5月期间,206例BAV患者(平均年龄53±14岁,84%为男性)接受了主动脉根部复合置换术。109例患者(53%)表现为主动脉瓣反流,24例患者(12%)表现为主动脉瓣狭窄,55例患者(26%)表现为主动脉瓣狭窄合并主动脉瓣反流。术前主动脉直径中位数为5.5 cm(范围3至9 cm)。22例患者(11%)接受了急诊或紧急手术;11例患有急性A型夹层(5%)。61%的患者使用了机械瓣膜Bentall假体;39%的患者植入了生物瓣膜。32%的患者进行了同期手术。
总体医院死亡率为2.9%(n = 6),卒中发生率为1.9%(n = 4)。不良结局(死亡或卒中)发生率为4.8%(n = 10),其危险因素为存在血栓或动脉粥样硬化(p = 0.02)以及年龄大于65岁(p = 0.05)。在平均5.9年的随访期(1200患者年;范围5至18患者年)内,无患者需要再次进行升主动脉手术。5年后长期生存率为93%,10年后为89%。出院患者的生存率与年龄和性别匹配的正常人群相当,且优于仅接受主动脉瓣置换的一系列患者的生存率报告。
对于BAV患者,Bentall手术的手术死亡率不高于主动脉瓣置换术,长期生存率更高,主动脉再次手术率更低。